Clinical Trial Update: Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Qingre Huatan Formula to prevent early neurological deterioration in patients with acute ischemic stroke, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Qingre Huatan Formula

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Acute Ischemic Stroke | Phase 1, Phase 2 | Status: RECRUITING